Medical Device for Tumor Cryo Ablation
Israeli company that develops and markets minimally invasive cryoablation therapies for women’s health and other areas. Our proprietary ProSense™ system provides minimally invasive, in-office definitive treatment for breast tumors, both benign and breast cancer (1).
It sells its products in the U.S (both direct and by distributors through its subsidiary's office in Memphis, Tennessee). Among the U.S clients are breast centers in reputable institutions as well as private clinics operated by breast surgeons and radiologists. In other geographies, it uses specialized distributors that provide clinical and technical sales support in Asia and Europe.
The company has FDA and CE approval for broad benign and malignant indications. It is also in advanced regulatory process in China with the CFDA as well as other Asian and South American countries.
Thanks to its unique and innovative technology, it participates in several clinical studies for treatment of other indications such as lung cancer, kidney cancer and breast cancer.
With the global trend of taking procedures from the operating room to the office environment and decreasing their costs, the company's innovation brings the future to the present!
(1) Under clinical studies in the U.S and Japan.
Potential Partners:
- Distributors with existing “GO-2-Market” to Breast Surgeons, GYN, Breast Radiologists
- Distributors with existing “GO-2-Market”interventional oncologists.
Target Countries: Europe, Asia, USA, Central & South America, Canada.
Company Info:
Year of Establishment: 2006
No. of Employees: 17
